You are previewing premium content. Sign up to GENSelect to read full article.
The NYGC’s ultimate goal is to develop a biotech cluster in New York that rivals those of Boston and San Francisco. [© dell - Fotolia.com]
If New York City is ever to become a top-tier biopharma cluster, the $125 million New York Genome Center (NYGC) set to start operations ...
For full access to this content and other high value GENSelect content & services, please sign in or register for FREE below.
LEARN MORE about GENSelect.
I forgot my password
I agree to the terms of genengnews.com
Unable to get Jobs Listings.
Have you ever experienced difficulty obtaining funds for a biotech enterprise?
Be sure to add email@example.com
to your Address Book or Safe Senders List.
here for instructions.
If you have any questions about your subscription, click
here to email us or call at (914) 740-2189.
You may also be interested in subscribing to the GEN magazine, an indispensable
resource for everyone involved in the business of translating discoveries at the
bench into solutions that fight disease and improve health, agriculture, and the
today to see why over 60,000 biotech professionals read GEN to
keep current in the areas of genomics, proteomics, drug discovery, biomarker discovery,
bioprocessing, molecular diagnostics, collaborations, biotech business trends, and
© 2013 Genetic Engineering & Biotechnology News All Rights Reserved